135.
    发明专利
    未知

    公开(公告)号:DE59410107D1

    公开(公告)日:2002-05-23

    申请号:DE59410107

    申请日:1994-12-21

    Applicant: BASF AG

    Abstract: PCT No. PCT/EP94/03839 Sec. 371 Date Jun. 20, 1997 Sec. 102(e) Date Jun. 20, 1997 PCT Filed Dec. 21, 1994 PCT Pub. No. WO96/19476 PCT Pub. Date Jun. 27, 1996Quinoxaline-2,3-(1H,4H)-diones of the formula I I and their tautomeric and enantiomeric forms and their physiologically tolerated salts, the variables R, R1 and R2 have the meanings specified in claim 1, and are useful for therapeutic treatment of neurodegenerative disorders, neurotoxic disturbances or as antiepileptics, antidepressants and anxiolytics; and drugs composed thereof.

    139.
    发明专利
    未知

    公开(公告)号:NO991132D0

    公开(公告)日:1999-03-09

    申请号:NO991132

    申请日:1999-03-09

    Applicant: BASF AG

    Abstract: A 3-substituted 3,4,5,6,7,8-hexahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidine compound of formula IwhereinR1 is hydrogen, C1-C4-alkyl, acetyl or benzoyl, optionally substituted phenyl-C1-C4-alkyl, naphthyl-C1-C3-alkyl, phenyl-C2-C3-alkanone or a phenylcarbamoyl-C2-alkyl,R2 is optionally substituted phenyl, pyridyl, pyrimidyl or pyrazinyl, or an optionally substituted bicyclus wherein one of the two fused rings is a phenyl, a pyridyl, a pyrimidyl or a pyrazinyl ring,A is NH or oxygen,B is hydrogen or methyl,C is hydrogen, methyl or hydroxyl,X is nitrogen,Y is CH2, CH2-C2, CH2-C2-CH2 or CH2-CH,Z is nitrogen, C or CH, and the linkage between Y and Z is a single or a double bond, andn is 2, 3 or 4,or a physiologically tolerated salt thereof, and compositions comprising them and their use as antagonists of 5HT1B and 5HT1A and for the treatment of depression and related disorders.

Patent Agency Ranking